Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome: Guidelines

Yukio Homma, Tomohiro Ueda, Hikaru Tomoe, Alex Tl Lin, Hann Chorng Kuo, Ming Huei Lee, Jeong Gu Lee, Duk Yoon Kim, Kyu Sung Lee

Research output: Contribution to journalReview article

125 Citations (Scopus)

Abstract

A clinical guideline and algorism for interstitial cystitis and hypersensitive bladder syndrome has been developed by a group of East Asian urologists as a revised form of the Japanese guideline for interstitial cystitis. The guideline defines interstitial cystitis (IC) as a disease of the urinary bladder diagnosed by 3 requirements; 1) a characteristic complex of lower urinary tract symptoms, 2) bladder pathology such as Hunner's ulcer and bladder bleeding after overdistension, and 3) exclusions of confusable diseases. The characteristic symptom complex is termed as hypersensitive bladder syndrome (HBS), which is defined as bladder hypersensitivity, usually associated with urinary frequency, with or without bladder pain. For the definite diagnosis of IC, cytoscopy or hydrodistension is crutial; HBS is the diagnosis when IC is suspected but not confirmed by the 3 requirements. Numerous therapeutic options are available; however, most of them lack in high level of evidence, leaving a few as recommended therapies. Etiology of IC are multifactorial; the interaction among nervous, immune and endocrine factors forms a vicious cycle, provocating and maintaining inflammatory reactions in the bladder. The inclusion and efficacy criteria for clinical trials should be standardized to enhance the clinical research for this disabling disease, which has proved to be more prevalent than previously believed.

Original languageEnglish
Pages (from-to)597-615
Number of pages19
JournalInternational Journal of Urology
Volume16
Issue number7
DOIs
Publication statusPublished - 2009 Jul 1

Fingerprint

Interstitial Cystitis
Urinary Bladder
Guidelines
Urinary Bladder Diseases
Lower Urinary Tract Symptoms
Immunologic Factors
Ulcer
Hypersensitivity
Clinical Trials
Pathology
Hemorrhage
Pain

Keywords

  • Bladder hypersensitivity
  • Guideline
  • Interstitial cystitis

ASJC Scopus subject areas

  • Urology

Cite this

Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome : Guidelines. / Homma, Yukio; Ueda, Tomohiro; Tomoe, Hikaru; Lin, Alex Tl; Kuo, Hann Chorng; Lee, Ming Huei; Lee, Jeong Gu; Kim, Duk Yoon; Lee, Kyu Sung.

In: International Journal of Urology, Vol. 16, No. 7, 01.07.2009, p. 597-615.

Research output: Contribution to journalReview article

Homma, Yukio ; Ueda, Tomohiro ; Tomoe, Hikaru ; Lin, Alex Tl ; Kuo, Hann Chorng ; Lee, Ming Huei ; Lee, Jeong Gu ; Kim, Duk Yoon ; Lee, Kyu Sung. / Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome : Guidelines. In: International Journal of Urology. 2009 ; Vol. 16, No. 7. pp. 597-615.
@article{4afa24b0103a4c8abdc56c48e1efe516,
title = "Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome: Guidelines",
abstract = "A clinical guideline and algorism for interstitial cystitis and hypersensitive bladder syndrome has been developed by a group of East Asian urologists as a revised form of the Japanese guideline for interstitial cystitis. The guideline defines interstitial cystitis (IC) as a disease of the urinary bladder diagnosed by 3 requirements; 1) a characteristic complex of lower urinary tract symptoms, 2) bladder pathology such as Hunner's ulcer and bladder bleeding after overdistension, and 3) exclusions of confusable diseases. The characteristic symptom complex is termed as hypersensitive bladder syndrome (HBS), which is defined as bladder hypersensitivity, usually associated with urinary frequency, with or without bladder pain. For the definite diagnosis of IC, cytoscopy or hydrodistension is crutial; HBS is the diagnosis when IC is suspected but not confirmed by the 3 requirements. Numerous therapeutic options are available; however, most of them lack in high level of evidence, leaving a few as recommended therapies. Etiology of IC are multifactorial; the interaction among nervous, immune and endocrine factors forms a vicious cycle, provocating and maintaining inflammatory reactions in the bladder. The inclusion and efficacy criteria for clinical trials should be standardized to enhance the clinical research for this disabling disease, which has proved to be more prevalent than previously believed.",
keywords = "Bladder hypersensitivity, Guideline, Interstitial cystitis",
author = "Yukio Homma and Tomohiro Ueda and Hikaru Tomoe and Lin, {Alex Tl} and Kuo, {Hann Chorng} and Lee, {Ming Huei} and Lee, {Jeong Gu} and Kim, {Duk Yoon} and Lee, {Kyu Sung}",
year = "2009",
month = "7",
day = "1",
doi = "10.1111/j.1442-2042.2009.02326.x",
language = "English",
volume = "16",
pages = "597--615",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome

T2 - Guidelines

AU - Homma, Yukio

AU - Ueda, Tomohiro

AU - Tomoe, Hikaru

AU - Lin, Alex Tl

AU - Kuo, Hann Chorng

AU - Lee, Ming Huei

AU - Lee, Jeong Gu

AU - Kim, Duk Yoon

AU - Lee, Kyu Sung

PY - 2009/7/1

Y1 - 2009/7/1

N2 - A clinical guideline and algorism for interstitial cystitis and hypersensitive bladder syndrome has been developed by a group of East Asian urologists as a revised form of the Japanese guideline for interstitial cystitis. The guideline defines interstitial cystitis (IC) as a disease of the urinary bladder diagnosed by 3 requirements; 1) a characteristic complex of lower urinary tract symptoms, 2) bladder pathology such as Hunner's ulcer and bladder bleeding after overdistension, and 3) exclusions of confusable diseases. The characteristic symptom complex is termed as hypersensitive bladder syndrome (HBS), which is defined as bladder hypersensitivity, usually associated with urinary frequency, with or without bladder pain. For the definite diagnosis of IC, cytoscopy or hydrodistension is crutial; HBS is the diagnosis when IC is suspected but not confirmed by the 3 requirements. Numerous therapeutic options are available; however, most of them lack in high level of evidence, leaving a few as recommended therapies. Etiology of IC are multifactorial; the interaction among nervous, immune and endocrine factors forms a vicious cycle, provocating and maintaining inflammatory reactions in the bladder. The inclusion and efficacy criteria for clinical trials should be standardized to enhance the clinical research for this disabling disease, which has proved to be more prevalent than previously believed.

AB - A clinical guideline and algorism for interstitial cystitis and hypersensitive bladder syndrome has been developed by a group of East Asian urologists as a revised form of the Japanese guideline for interstitial cystitis. The guideline defines interstitial cystitis (IC) as a disease of the urinary bladder diagnosed by 3 requirements; 1) a characteristic complex of lower urinary tract symptoms, 2) bladder pathology such as Hunner's ulcer and bladder bleeding after overdistension, and 3) exclusions of confusable diseases. The characteristic symptom complex is termed as hypersensitive bladder syndrome (HBS), which is defined as bladder hypersensitivity, usually associated with urinary frequency, with or without bladder pain. For the definite diagnosis of IC, cytoscopy or hydrodistension is crutial; HBS is the diagnosis when IC is suspected but not confirmed by the 3 requirements. Numerous therapeutic options are available; however, most of them lack in high level of evidence, leaving a few as recommended therapies. Etiology of IC are multifactorial; the interaction among nervous, immune and endocrine factors forms a vicious cycle, provocating and maintaining inflammatory reactions in the bladder. The inclusion and efficacy criteria for clinical trials should be standardized to enhance the clinical research for this disabling disease, which has proved to be more prevalent than previously believed.

KW - Bladder hypersensitivity

KW - Guideline

KW - Interstitial cystitis

UR - http://www.scopus.com/inward/record.url?scp=68249099454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249099454&partnerID=8YFLogxK

U2 - 10.1111/j.1442-2042.2009.02326.x

DO - 10.1111/j.1442-2042.2009.02326.x

M3 - Review article

C2 - 19548999

AN - SCOPUS:68249099454

VL - 16

SP - 597

EP - 615

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 7

ER -